Skip to Content

K U 712 (Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg)

Pill with imprint K U 712 is Yellow, Figure eight-shape and has been identified as Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg. It is supplied by Cobalt Laboratories Inc.

Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for K U 712

Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg K U 712
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg K U 712
Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 7.5 mg K U 712

Hydrochlorothiazide and moexipril hydrochloride

Imprint:
K U 712
Strength:
12.5 mg / 7.5 mg
Color:
Yellow
Size:
11.00 mm
Shape:
Figure eight-shape
Availability:
Prescription only
Drug Class:
ACE inhibitors with thiazides
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cobalt Laboratories Inc
Inactive Ingredients:
lactose
magnesium oxide
crospovidone
magnesium stearate
gelatin
hydroxypropyl cellulose
hypromellose
polyethylene glycol 6000
titanium dioxide
ferric oxide red
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide